StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$2.02−0.02 (-0.98%)

Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –

Compugen price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Compugen's price to sales ratio was 2.7× on Nov 11, 2026, against 5.2× a year earlier. Over the last 5 years it ranged from 2.6× to 180.4×, with a median of 6.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.7×−2.4
2025Dec 31, 20255.1×+1.0
2024Dec 31, 20244.1×−19.2
2023Dec 29, 202323.3×+13.0
2022Dec 30, 202210.3×−170.1
2021Dec 31, 2021180.4×+145.8
2020Feb 28, 202034.6×+13.9
2019Dec 31, 201920.7×−267.4
2018Feb 28, 2018288.2×+108.6
2017Dec 29, 2017179.5×+151.6
2016Dec 30, 201628.0×+1.9
2015Dec 31, 201526.1×−87.7
2014Dec 31, 2014113.8×−77.0
2012Feb 29, 2012190.8×+40.2
2011Dec 30, 2011150.6×−347.7
2010Nov 30, 2010498.3×–

More Compugen figures

See a number that looks wrong?